HomeCompareVIAAX vs MRK

VIAAX vs MRK: Dividend Comparison 2026

VIAAX yields 2.20% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $33.8K in total portfolio value
10 years
VIAAX
VIAAX
● Live price
2.20%
Share price
$42.98
Annual div
$0.95
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.9K
Annual income
$253.71
Full VIAAX calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — VIAAX vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVIAAXMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VIAAX + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VIAAX pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VIAAX
Annual income on $10K today (after 15% tax)
$187.07/yr
After 10yr DRIP, annual income (after tax)
$215.65/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,112.76/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VIAAX + MRK for your $10,000?

VIAAX: 50%MRK: 50%
100% MRK50/50100% VIAAX
Portfolio after 10yr
$39.9K
Annual income
$5,025.93/yr
Blended yield
12.61%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

VIAAX
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VIAAX buys
0
MRK buys
0
No recent congressional trades found for VIAAX or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVIAAXMRK
Forward yield2.20%2.76%
Annual dividend / share$0.95$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$22.9K$56.8K
Annual income after 10y$253.71$9,798.13
Total dividends collected$2.4K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: VIAAX vs MRK ($10,000, DRIP)

YearVIAAX PortfolioVIAAX Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,920$220.08$11,206$366.19$286.00MRK
2$11,909$224.61$12,650$502.35$741.00MRK
3$12,972$228.92$14,407$694.19$1.4KMRK
4$14,113$233.04$16,585$967.82$2.5KMRK
5$15,338$236.95$19,342$1,363.89$4.0KMRK
6$16,652$240.67$22,913$1,947.19$6.3KMRK
7$18,062$244.20$27,662$2,823.89$9.6KMRK
8$19,574$247.54$34,159$4,173.35$14.6KMRK
9$21,194$250.71$43,337$6,308.80$22.1KMRK
10$22,932$253.71$56,776$9,798.13$33.8KMRK

VIAAX vs MRK: Complete Analysis 2026

VIAAXStock

This fund offers investors a low cost way to gain exposure to high-quality international companies that have both the ability and the commitment to grow their dividends over time. The fund seeks to track a modified market cap weighted benchmark of all-capitalization developed and emerging markets stocks outside the United States with a history of increasing annual dividend payments. Because it invests in non-U.S. stocks, the fund can be more volatile than a domestic fund. Another risk is the possibility that returns from dividend-paying stocks will trail returns from the overall stock market during any given period. This fund may be appropriate for long-term investors seeking some income and exposure to international dividend-focused companies.With respect to 75% of its total assets, the fund may not: (1) purchase more than 10% of the outstanding voting securities of any one issuer or (2) purchase securities of any issuer if, as a result, more than 5% of the fund’s total assets would be invested in that issuer’s securities; except as may be necessary to approximate the composition of its target index. This limitation does not apply to obligations of the U.S. government or its agencies or instrumentalities.

Full VIAAX Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this VIAAX vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VIAAX vs SCHDVIAAX vs JEPIVIAAX vs OVIAAX vs KOVIAAX vs MAINVIAAX vs JNJVIAAX vs ABBVVIAAX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.